Ciclazindol
![]() |
|
Systematic (IUPAC) name | |
---|---|
10-(3-chlorophenyl)-3,4-dihydro-2H-pyrimido[1,2-a]indol-10-ol
|
|
Clinical data | |
Legal status |
|
Routes of administration |
Oral |
Pharmacokinetic data | |
Metabolism | Renal[1] |
Biological half-life | ~32 hours[1] |
Excretion | Urine, feces[1] |
Identifiers | |
CAS Number | 37751-39-6 |
ATC code | none |
PubChem | CID: 37825 |
ChemSpider | 34683 |
UNII | Y3I9520J7P ![]() |
KEGG | D03486 |
ChEMBL | CHEMBL1192491 |
Chemical data | |
Formula | C17H15ClN2O |
Molecular mass | 298.77 g/mol |
|
|
Ciclazindol (WY-23,409) is an antidepressant and anorectic drug of the tetracyclic chemical class that was developed in the mid to late 1970s, but was never marketed.[2][3] It acts as a norepinephrine reuptake inhibitor, and to a lesser extent as a dopamine reuptake inhibitor.[2][4] Ciclazindol has no effects on the SERT, 5-HT receptors, mACh receptors, or α-adrenergic receptors, and has only weak affinity for the H1 receptor.[4][5][6] As suggested by its local anesthetic properties,[5] ciclazindol may also inhibit sodium channels. It is known to block potassium channels as well.[7][8]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
Central |
|
||||||
---|---|---|---|---|---|---|---|
Peripheral | |||||||
|
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
Classes | |
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- ↑ 1.0 1.1 1.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 4.0 4.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 5.0 5.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Alcohols
- Anorectics
- Norepinephrine reuptake inhibitors
- Chloroarenes
- Gastrointestinal system drug stubs
- Nervous system drug stubs